Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor‐α positive ovarian cancer: The antibody–drug conjugate, payload and metabolite.
Saved in:
| Title: | Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor‐α positive ovarian cancer: The antibody–drug conjugate, payload and metabolite. |
|---|---|
| Authors: | Tu, Ya‐Ping1 (AUTHOR) yaping.tu@immunogen.com, Hanze, Eva2 (AUTHOR), Zhu, Fengying3 (AUTHOR), Lagraauw, H. Maxime4 (AUTHOR), Sloss, Callum M.5 (AUTHOR), Method, Michael6 (AUTHOR), Esteves, Brooke6 (AUTHOR), Westin, Eric H.6 (AUTHOR), Berkenblit, Anna6 (AUTHOR) |
| Source: | British Journal of Clinical Pharmacology. Feb2024, Vol. 90 Issue 2, p568-581. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 175139709 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor‐α positive ovarian cancer: The antibody–drug conjugate, payload and metabolite. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Tu%2C+Ya‐Ping%22">Tu, Ya‐Ping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yaping.tu@immunogen.com</i><br /><searchLink fieldCode="AR" term="%22Hanze%2C+Eva%22">Hanze, Eva</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Fengying%22">Zhu, Fengying</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lagraauw%2C+H%2E+Maxime%22">Lagraauw, H. Maxime</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sloss%2C+Callum+M%2E%22">Sloss, Callum M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Method%2C+Michael%22">Method, Michael</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Esteves%2C+Brooke%22">Esteves, Brooke</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Westin%2C+Eric+H%2E%22">Westin, Eric H.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berkenblit%2C+Anna%22">Berkenblit, Anna</searchLink><relatesTo>6</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Clinical+Pharmacology%22">British Journal of Clinical Pharmacology</searchLink>. Feb2024, Vol. 90 Issue 2, p568-581. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175139709 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bcp.15937 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 568 Titles: – TitleFull: Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor‐α positive ovarian cancer: The antibody–drug conjugate, payload and metabolite. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tu, Ya‐Ping – PersonEntity: Name: NameFull: Hanze, Eva – PersonEntity: Name: NameFull: Zhu, Fengying – PersonEntity: Name: NameFull: Lagraauw, H. Maxime – PersonEntity: Name: NameFull: Sloss, Callum M. – PersonEntity: Name: NameFull: Method, Michael – PersonEntity: Name: NameFull: Esteves, Brooke – PersonEntity: Name: NameFull: Westin, Eric H. – PersonEntity: Name: NameFull: Berkenblit, Anna IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 03065251 Numbering: – Type: volume Value: 90 – Type: issue Value: 2 Titles: – TitleFull: British Journal of Clinical Pharmacology Type: main |
| ResultId | 1 |
